AI assistant
Sending…
Processa Pharmaceuticals, Inc. — Director's Dealing 2025
Apr 11, 2025
35172_dirs_2025-04-11_0abb0b08-c7e3-4c06-b2a0-9b7f61f30e28.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2025-04-11
Reporting Person: Bigora Sian (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-04-01 | Common Stock | M | 15059 | — | Acquired | 36937 | Direct |
| 2025-04-01 | Common Stock | F | 3311 | $0.412 | Disposed | 33626 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6668 | Indirect |
Footnotes
F1: Distribution of vested restricted shares.
More from Processa Pharmaceuticals, Inc.
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Regulatory Filings
2026
Jan 7
Regulatory Filings
2025
Dec 15
Major Shareholding Notification
2025
Nov 7
Interim / Quarterly Report
2025
Nov 6
Major Shareholding Notification
2025
Oct 15